Literature DB >> 18815308

Role of T cells in virus control and disease after infection with pneumonia virus of mice.

Stefanie Frey1, Christine D Krempl, Annette Schmitt-Gräff, Stephan Ehl.   

Abstract

Infection of mice with pneumonia virus of mice (PVM) is used as a natural host experimental model for studying the pathogenesis of infection with the closely related human respiratory syncytial virus. We analyzed the contribution of T cells to virus control and pathology after PVM infection. Control of a sublethal infection with PVM strain 15 in C57BL/6 mice was accompanied by a 100-fold increase in pulmonary cytotoxic T lymphocytes, 20% of which were specific for PVM. T-cell-deficient mice failed to eliminate PVM and became virus carriers in the absence of the clinical or histopathological signs of pneumonia that occurred after infection of control mice. Mice with limited T-cell numbers did not achieve virus control without weight loss, indicating that T-cell-mediated virus control was closely linked to immunopathology. Both CD4 and CD8 T cells independently contributed to virus elimination and disease. Virus control and disease were similar in the absence of perforin, gamma interferon, or tumor necrosis factor alpha. Interestingly, disease and mortality after lethal high-dose PVM infection were independent of T cells. These data illustrate a key role for T cells in control of PVM infection and demonstrate that both T-cell-dependent and -independent pathways contribute to disease in a viral dose-dependent fashion.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18815308      PMCID: PMC2583671          DOI: 10.1128/JVI.00375-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

1.  Glucocorticoid administration accelerates mortality of pneumovirus-infected mice.

Authors:  J B Domachowske; C A Bonville; D Ali-Ahmad; K D Dyer; A J Easton; H F Rosenberg
Journal:  J Infect Dis       Date:  2001-12-03       Impact factor: 5.226

2.  Respiratory syncytial virus infection suppresses lung CD8+ T-cell effector activity and peripheral CD8+ T-cell memory in the respiratory tract.

Authors:  Jun Chang; Thomas J Braciale
Journal:  Nat Med       Date:  2002-01       Impact factor: 53.440

3.  Long-term persistence and reactivation of T cell memory in the lung of mice infected with respiratory syncytial virus.

Authors:  T Ostler; T Hussell; C D Surh; P Openshaw; S Ehl
Journal:  Eur J Immunol       Date:  2001-09       Impact factor: 5.532

4.  Inhibition of tumor necrosis factor reduces the severity of virus-specific lung immunopathology.

Authors:  T Hussell; A Pennycook; P J Openshaw
Journal:  Eur J Immunol       Date:  2001-09       Impact factor: 5.532

5.  Pulmonary eosinophilia and production of MIP-1alpha are prominent responses to infection with pneumonia virus of mice.

Authors:  J B Domachowske; C A Bonville; K D Dyer; A J Easton; H F Rosenberg
Journal:  Cell Immunol       Date:  2000-03-15       Impact factor: 4.868

6.  Virus clearance and immunopathology by CD8(+) T cells during infection with respiratory syncytial virus are mediated by IFN-gamma.

Authors:  Tobias Ostler; Wendy Davidson; Stephan Ehl
Journal:  Eur J Immunol       Date:  2002-08       Impact factor: 5.532

7.  Pulmonary T cells induced by respiratory syncytial virus are functional and can make an important contribution to long-lived protective immunity.

Authors:  Tobias Ostler; Stephan Ehl
Journal:  Eur J Immunol       Date:  2002-09       Impact factor: 5.532

Review 8.  Emerging role of gammadelta T-cells in health and disease.

Authors:  Mahmoud Aljurf; Adnan Ezzat; Mohamed O Musa
Journal:  Blood Rev       Date:  2002-12       Impact factor: 8.250

9.  Differential expression of proinflammatory cytokine genes in vivo in response to pathogenic and nonpathogenic pneumovirus infections.

Authors:  Joseph B Domachowske; Cynthia A Bonville; Andrew J Easton; Helene F Rosenberg
Journal:  J Infect Dis       Date:  2002-06-14       Impact factor: 5.226

10.  CD8+ T cell responses in bronchoalveolar lavage fluid and peripheral blood mononuclear cells of infants with severe primary respiratory syncytial virus infections.

Authors:  Jojanneke Heidema; Michaël V Lukens; Wendy W C van Maren; Mariska E A van Dijk; Henny G Otten; Adrianus J van Vught; Desiree B M van der Werff; Sjef J P van Gestel; Malcolm G Semple; Rosalind L Smyth; Jan L L Kimpen; Grada M van Bleek
Journal:  J Immunol       Date:  2007-12-15       Impact factor: 5.422

View more
  25 in total

1.  Critical Adverse Impact of IL-6 in Acute Pneumovirus Infection.

Authors:  Caroline M Percopo; Michelle Ma; Todd A Brenner; Julia O Krumholz; Timothy J Break; Karen Laky; Helene F Rosenberg
Journal:  J Immunol       Date:  2018-12-21       Impact factor: 5.422

2.  Canine pneumovirus replicates in mouse lung tissue and elicits inflammatory pathology.

Authors:  Caroline M Percopo; Edward J Dubovi; Randall W Renshaw; Kimberly D Dyer; Joseph B Domachowske; Helene F Rosenberg
Journal:  Virology       Date:  2011-05-20       Impact factor: 3.616

3.  Administration of immunobiotic Lactobacillus plantarum delays but does not prevent lethal pneumovirus infection in Rag1-/- mice.

Authors:  Caroline M Percopo; Michelle Ma; Helene F Rosenberg
Journal:  J Leukoc Biol       Date:  2017-06-15       Impact factor: 4.962

4.  Contribution of Human Lung Parenchyma and Leukocyte Influx to Oxidative Stress and Immune System-Mediated Pathology following Nipah Virus Infection.

Authors:  Olivier Escaffre; Tais B Saito; Terry L Juelich; Tetsuro Ikegami; Jennifer K Smith; David D Perez; Colm Atkins; Corri B Levine; Matthew B Huante; Rebecca J Nusbaum; Janice J Endsley; Alexander N Freiberg; Barry Rockx
Journal:  J Virol       Date:  2017-07-12       Impact factor: 5.103

5.  Effects of tumor necrosis factor on viral replication and pulmonary inflammation during acute mouse adenovirus type 1 respiratory infection.

Authors:  Krittika Pant; Adithya Chandrasekaran; Christine J Chang; Aditya Vageesh; Alexandra J Popkov; Jason B Weinberg
Journal:  Virology       Date:  2020-05-23       Impact factor: 3.616

6.  Animal model of respiratory syncytial virus: CD8+ T cells cause a cytokine storm that is chemically tractable by sphingosine-1-phosphate 1 receptor agonist therapy.

Authors:  Kevin B Walsh; John R Teijaro; Linda G Brock; Daniel M Fremgen; Peter L Collins; Hugh Rosen; Michael B A Oldstone
Journal:  J Virol       Date:  2014-03-26       Impact factor: 5.103

7.  Depletion of alveolar macrophages prolongs survival in response to acute pneumovirus infection.

Authors:  Peter Rigaux; Kristin E Killoran; Zhijun Qiu; Helene F Rosenberg
Journal:  Virology       Date:  2011-11-30       Impact factor: 3.616

8.  Granzyme A- and B-cluster deficiency delays acute lung injury in pneumovirus-infected mice.

Authors:  Reinout A Bem; Job B M van Woensel; Rene Lutter; Joseph B Domachowske; Jan Paul Medema; Helene F Rosenberg; Albert P Bos
Journal:  J Immunol       Date:  2009-12-16       Impact factor: 5.422

9.  Pulse-oximetry accurately predicts lung pathology and the immune response during influenza infection.

Authors:  David Verhoeven; John R Teijaro; Donna L Farber
Journal:  Virology       Date:  2009-06-02       Impact factor: 3.616

10.  Sustained inflammation and differential expression of interferons type I and III in PVM-infected interferon-gamma (IFNγ) gene-deleted mice.

Authors:  Stephanie F Glineur; Aaron B Bowen; Caroline M Percopo; Katia E Garcia-Crespo; Kimberly D Dyer; Sergei I Ochkur; Nancy A Lee; James J Lee; Joseph B Domachowske; Helene F Rosenberg
Journal:  Virology       Date:  2014-08-28       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.